Mohammad Krayem

Has grant

Université libre de Bruxelles (ULB)

Belgium

Research Interests

Explore related searches

Professors in Belgium Professors in Cancer Biology Cancer Biology professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Scientific Collaborator

Open Date:

Close Date:

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

An Wouters

Prof. dr. at University of Antwerp

University of Antwerp

BELGIUM

View details

Hamza AlGhamdi

Institut Jules Bordet

BELGIUM

View details

Benedikt Engels

Vrije Universiteit Brussel

BELGIUM

View details

Dirk Van Gestel

Université libre de Bruxelles

BELGIUM

View details

Ahmad Awada

Université libre de Bruxelles (ULB)

BELGIUM

View details

Mathilde Wells

Assistant professor

University of Mons

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mohammad Krayem

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (11)

Correction: Krayem et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance. Cancers 2020, 12, 512

Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies

Correction: Krayem et al. The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma. Cancers 2019, 11, 1093

Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance

The Road to Dissemination: The Concept of Oligometastases and the Barriers for Widespread Disease

Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma

RTK Inhibitors in Melanoma: From Bench to Bedside

Erratum: Krayem, M., et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma. Cancers 2020, 12, 512

Toad Venom Antiproliferative Activities on Metastatic Melanoma: Bio-Guided Fractionation and Screening of the Compounds of Two Different Venoms

Metabolic Reprogramming in Metastatic Melanoma with Acquired Resistance to Targeted Therapies: Integrative Metabolomic and Proteomic Analysis

Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance

Collaborators (6)

An Wouters

Hamza AlGhamdi

Benedikt Engels

Dirk Van Gestel

Ahmad Awada

Mathilde Wells

Make your next move.